Acquiring an existing Medicare-certified agency gets you immediate revenue, an active patient census, and established referral relationships — but starting fresh gives you full control over culture, compliance posture, and operational systems. The right choice depends on your capital, timeline, and risk tolerance.
Home health is one of the most attractive sectors in lower middle market healthcare investing. With a $113 billion U.S. market growing toward $170 billion by 2030, an aging Baby Boomer population driving demand, and CMS actively incentivizing home-based care over institutional settings, the fundamental case for entering the industry is compelling. But the path you choose — acquiring an established agency versus building one from the ground up — carries dramatically different cost structures, timelines, and regulatory complexities. Acquiring an existing agency means purchasing active Medicare and Medicaid certifications, an enrolled patient census, credentialed clinical staff, and referral source relationships that took years to build. Building from scratch means navigating a 6–18 month CMS certification process, a state licensure pipeline, and a hiring challenge in one of the tightest clinical labor markets in the country — all before you bill your first claim. Neither path is universally superior. The right answer depends on how quickly you need cash flow, how much capital you can deploy, whether you can tolerate regulatory startup risk, and whether you have the clinical and operational expertise to run a compliant operation from day one.
Find Home Health Agency Businesses to AcquireAcquiring an existing home health agency gives you immediate access to a Medicare/Medicaid-certified operation with an active patient census, credentialed staff, and established physician and hospital referral relationships. You avoid the 6–18 month CMS certification window entirely and inherit a business with 2–3 years of proven revenue and margin history. For buyers using SBA 7(a) financing, you can often structure the acquisition with 10% equity, a seller note, and a holdback tied to successful CHOW approval — reducing upfront cash requirements while protecting against post-close surprises.
PE-backed roll-up platforms seeking geographic expansion, regional healthcare operators adding coverage areas, and individual buyers with clinical or healthcare management backgrounds who want immediate cash flow and can underwrite regulatory and staff retention risk through disciplined due diligence.
Building a home health agency from scratch — often called a de novo startup — gives you complete control over compliance infrastructure, clinical culture, technology stack, and billing systems. You avoid inheriting someone else's regulatory problems. However, the path to Medicare and Medicaid certification is lengthy, expensive, and uncertain. CMS enrollment for new home health agencies is heavily scrutinized, many states have imposed moratoria on new agency licensure, and you will need 12–24 months of operating capital before the business reaches sustainable cash flow.
Experienced home health operators, clinical founders with existing referral networks, or investors entering markets where no quality agencies are available for acquisition and state licensure moratoria do not apply. Also viable for operators in states without moratoria who want full control over compliance infrastructure and are willing to accept an 18–24 month cash flow delay.
For most buyers entering the home health space at the $1M–$5M revenue level, acquisition is the superior path. The barriers to building a de novo home health agency — state licensure moratoria, CMS enrollment delays, clinical labor shortages, and a 12–24 month cash flow desert — make organic startup a high-risk, capital-intensive strategy that only makes sense in specific geographies where no suitable acquisition targets exist. Acquiring a Medicare-certified agency with a clean compliance history, diversified payor mix, strong CMS star ratings, and an active patient census gives you an immediate, underwritable business with a proven track record. The key is disciplined due diligence: a third-party billing compliance audit, a thorough review of all CMS survey history and OASIS outcomes, and a realistic plan for managing the CHOW timeline and staff retention through the transition. Buyers who do this well can acquire a cash-flowing home health agency using SBA financing with 10% equity and generate strong returns in a market with powerful demographic tailwinds. Build only if you have clinical domain expertise, existing referral relationships, and operating capital to sustain 18+ months without Medicare reimbursement.
Is the target state open to new home health agency licensure, or does it have a certificate-of-need requirement or active moratorium that makes de novo entry legally impossible or prohibitively slow?
Do you have 12–24 months of operating capital reserves available to fund a startup through CMS certification and patient census ramp-up, or do you need a business that generates cash flow within 90–120 days of transaction close?
Do you have existing physician, hospital, or skilled nursing facility referral relationships in the target market that could seed an early patient census, or would you be starting from zero against established competitors?
Are there quality acquisition targets available in your target geography — agencies with clean CMS compliance histories, Medicare star ratings of 3.5 or above, diversified payor mix, and a capable non-owner clinical team — at valuations that work within your capital structure?
What is your risk tolerance for inherited compliance exposure versus startup regulatory risk — are you better equipped to underwrite existing billing and certification history through due diligence, or to build a clean compliance infrastructure from scratch?
Browse Home Health Agency Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
The CHOW process with CMS typically takes 60–120 days from the date of the transaction, depending on CMS workload, the MAC (Medicare Administrative Contractor) processing your region, and whether the seller's certification history is clean. During this period, the new owner cannot bill under their own provider number. Most acquisitions address this by including a transition services or management agreement that allows the seller to continue billing during the CHOW window, with proceeds flowing to the buyer. Your healthcare M&A attorney should draft this carefully to avoid anti-kickback or assignment of benefits issues.
The five most serious red flags in home health acquisitions are: (1) open CMS overpayment demands or active RAC audit investigations, which can result in significant post-close liability; (2) Medicare star ratings below 3.0, indicating systemic clinical quality or documentation deficiencies; (3) revenue concentration where a single referral source — such as one hospital system — accounts for more than 40–50% of admissions; (4) EVV non-compliance or outdated billing systems that signal fraud exposure risk; and (5) heavy owner dependency, where the selling nurse or therapist founder is personally managing all clinical relationships and no capable non-owner leadership exists to sustain operations post-transition.
Yes. Home health agency acquisitions are SBA 7(a) eligible, and the SBA loan program is one of the most common financing structures in lower middle market healthcare acquisitions. A typical deal might be structured with 10% buyer equity injection, 10–15% seller note, and 75–80% SBA 7(a) financing. The SBA will require a business valuation, 3 years of business tax returns, and confirmation that the acquired agency has positive historical cash flow sufficient to service the debt. One important nuance: the SBA lender will want to understand the CHOW timeline and ensure that Medicare certification will transfer successfully before funding. Working with an SBA lender experienced in healthcare acquisitions is strongly recommended.
Yes. Several states have certificate-of-need (CON) laws or active moratoria on new home health agency licensure, effectively preventing de novo entry. States including Florida, New York, and Illinois have historically maintained restrictive entry regulations for home health. In these markets, acquisition is not just preferred — it is often the only viable path to entering the industry. Even in states without formal moratoria, CMS has significantly tightened the Medicare enrollment process for new home health agencies in response to fraud concerns, making the timeline and approval certainty for startups materially worse than they were a decade ago.
Home health agencies in the lower middle market typically trade at 3.5x–6x EBITDA, with the multiple driven by CMS star ratings, payor mix quality, geographic market characteristics, patient census size, and management team depth. EBITDA margins for well-run agencies typically range from 10–20%. When underwriting, normalize EBITDA carefully by adding back owner compensation above market rate, personal expenses run through the business, and any one-time costs. Then stress-test the revenue by analyzing payor mix — what percentage comes from Medicare, Medicaid, managed care, and private pay — and model scenarios where CMS reimbursement rates compress under PDGM. Also review claim denial rates and historical billing compliance to identify any revenue that may be at risk of clawback.
More Home Health Agency Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers